Chlamydia reinfection means catching Chlamydia trachomatis again after you were already cured. This isn't your antibiotics failing; the usual cause is sex with an untreated partner. Because reinfection is common and silent, the CDC recommends everyone treated for chlamydia get retested about three months later CDC STI Tx Guidelines.

Reported US cases by infection, 2023 (Reported cases) Chlamydia: 1,648,568; Gonorrhea: 601,319; Syphilis (P&S): 53,007 Chlamydia 1,648,568 Gonorrhea 601,319 Syphilis (P&S) 53,007
Reported US cases by infection, 2023. Chlamydia is by far the most-reported STI — about 1.65 million cases in 2023. Source: CDC AtlasPlus, 2023.
Reported US cases by infection, 2023 (Reported cases)
ItemReported cases
Chlamydia1,648,568
Gonorrhea601,319
Syphilis (P&S)53,007

Why chlamydia reinfection happens

Curing chlamydia gives you no lasting immunity. The antibiotics clear the bacteria you have, but they don't leave behind antibodies that protect you the next time you're exposed. If you're exposed again — most often through a partner who was never treated — you can pick it right back up.

The single biggest driver is what clinicians call 'ping-pong' reinfection: you take your pills, feel fine, then resume sex with the same partner who still carries the infection and never got treated. Most chlamydia is silent. No discharge, no burning, nothing. A partner can pass it to you without either of you suspecting a thing, so treating the bacteria in your own body solves only half the problem.

Chlamydia is the most commonly reported bacterial STI in the US, with roughly 1.65 million reported cases in 2023, about 492 per 100,000 people, a rate that's stayed fairly flat in recent years CDC AtlasPlus, 2023. Rates run far higher in some places, with Washington DC, Louisiana, and Mississippi all more than double the national rate. High background prevalence means re-exposure is common, especially among people under 25.

Reinfection is not treatment failure

This distinction matters because the fix is different. Treatment failure means the drug didn't clear the original infection, which is uncommon with a properly taken course. Reinfection means the drug worked, you were clear, and then you got it again. The vast majority of positive tests after treatment are reinfections rather than failures.

Two things prevent it. First, partners. Anyone you had sex with in the prior 60 days should be tested or presumptively treated, and you should both abstain from sex for seven days after single-dose therapy or until a multi-day course is finished, otherwise you re-expose each other. Expedited partner therapy (giving you medication or a prescription to hand to your partner) is an option, and a landmark randomized trial found it cut persistent or repeat infection NEJM, Golden et al.. EPT is permissible in most US states but not all, so confirm it's legal where you live.

Second, the three-month retest. The CDC advises retesting everyone treated for chlamydia about three months after treatment. This is a reinfection screen, not a test-of-cure, timed to catch a new infection picked up after you finished your pills. Put it in your calendar the day you start treatment. For a full rundown of the regimens, see our guide to chlamydia treatment.

How to tell reinfection from a missed cure

If you test positive again, a clinician walks through a short differential to decide whether the original infection was ever cleared or whether you caught it fresh.

  • Did you finish the full course? The preferred regimen is doxycycline twice daily for a week. Missing doses, vomiting pills, or stopping early can leave bacteria behind, which is failure-by-adherence rather than reinfection.
  • Did you and your partner abstain long enough? Sex during the abstinence window, or with an untreated partner afterward, points to reinfection.
  • Was the infection rectal? The old single-dose azithromycin cleared rectal chlamydia poorly, with one randomized trial finding 100% cure with doxycycline versus 74% with azithromycin RCT, Clin Infect Dis. If you were treated with azithromycin for a rectal infection, a persistent positive may reflect incomplete clearance rather than a new exposure.
  • How soon did the positive return? A positive a few days to weeks out can reflect residual bacterial DNA the NAAT still detects, which is why test-of-cure isn't routinely advised. A positive months later, after re-exposure, is almost always reinfection.

Test-of-cure — retesting to confirm the bug is gone — isn't recommended for non-pregnant people unless adherence is in doubt, symptoms persist, or reinfection is suspected. Pregnant people are the exception: they get a test-of-cure about four weeks after finishing treatment and a retest at three months. For how the lab side works, see chlamydia testing & diagnosis.

Lymphogranuloma venereum (LGV)

LGV is caused by more invasive strains of the same bacterium (serovars L1–L3) and behaves differently, with the highest burden among men who have sex with men. It usually shows up as proctocolitis, with mucoid or bloody rectal discharge, anal pain, and tenesmus (the painful, constant urge to pass stool). It needs a longer course of doxycycline than ordinary genital chlamydia CDC LGV guidance, so a persistent rectal infection should prompt a clinician to consider LGV rather than assuming simple reinfection.

Preventing chlamydia reinfection next time

Condoms used correctly every time reduce transmission, and a long-term mutually monogamous relationship with a tested partner is protective. But because most infections cause no symptoms, the steps that actually move the needle are routine screening and getting partners treated.

  • Treat partners, every time. This is the most important single step. An untreated partner is the main route back to reinfection.
  • Use the abstinence window. Wait the full week after treatment before resuming sex, so neither of you re-seeds the other.
  • Take doxycycline correctly. Take it with food and avoid strong sun, since it can make skin more sun-sensitive; finishing the course matters.
  • Consider DoxyPEP if you're eligible. Taking a dose of doxycycline within 72 hours of sex reduces chlamydia by more than 70% CDC DoxyPEP, 2024. The CDC offers it to gay and bisexual men and transgender women who've had a bacterial STI in the past year, so discuss whether it fits your situation.
  • Keep screening on schedule. The USPSTF gives a Grade B recommendation to screen sexually active women 24 and under USPSTF. If you're in a higher-risk group, more frequent testing catches infections before they spread.

When to retest after chlamydia treatment

The timing depends on what you're checking for. The difference between confirming a cure and screening for a new infection:

PurposeWhoWhen
Reinfection retest (recommended for all)Everyone treated for chlamydiaAbout 3 months after treatment
Test-of-cure (not routine)Non-pregnant only if adherence in doubt, symptoms persist, or reinfection suspectedAfter symptoms/concern arise
Test-of-cure (pregnancy)Pregnant people~4 weeks after finishing treatment, plus a 3-month retest

The recommended method is a NAAT (nucleic acid amplification test), which is the most sensitive option for both genital and extragenital sites. Specimens can be a first-catch urine sample, a vaginal or cervical swab, or a urethral, rectal, or pharyngeal swab depending on where you may have been exposed. If you're testing after a new exposure rather than a treatment follow-up, our guide on when to test after exposure explains the timing, and you can get tested or compare testing providers to find an option that fits.

When to see a clinician

Most chlamydia care is straightforward, but some situations need a clinician's eyes rather than a repeat home test:

  • Symptoms that persist or return after you finished treatment — pelvic or lower-abdominal pain, abnormal discharge, bleeding between periods, or pain with sex.
  • In men, testicular pain, swelling, or fever, which can signal epididymitis (inflammation of the coiled tube behind the testicle that can, rarely, affect fertility).
  • Lower-abdominal or pelvic pain, fever, or pain during sex in women — possible pelvic inflammatory disease (PID), where infection spreads upward and can scar the fallopian tubes, raising the risk of ectopic pregnancy and infertility.
  • Joint pain, eye irritation, or urinary symptoms appearing together — a pattern called reactive arthritis that can follow infection.
  • Rectal discharge, anal pain, or the urge-to-go that won't quit, which should prompt evaluation for LGV.
  • Pregnancy, where both a test-of-cure and the three-month retest are part of standard care, since untreated infection can cause newborn pneumonia and conjunctivitis.

Untreated chlamydia can also increase the risk of acquiring or transmitting HIV, one more reason not to let a reinfection sit. If your symptoms overlap with another infection, our comparison of chlamydia vs gonorrhea explains how they differ and why they're often tested together.